Not logged in Share Save
Outcome of Subsequent Therapies After 177Lu-Vipivotide Tetraxetan for Metastatic Castrate-Resistant Prostate Cancer: A Tertiary Cancer Center Experience Losee, Meryam; Kavanaugh, Michael; Liu, Mofei; Borges, Nuno; Haberman, Veronica; Ritzer, Jolivette; Wolanski, Andrew; Bhimaniya, Sudhir; Choudhury, Atish D.; Hyun, Hyewon; Stoltenberg, Hailey; Kilbridge, Kerry L.; Morgans, Alicia; Pomerantz, Mark; Robertson, Matthew; Sakellis, Christopher; Shah, Hina; Taplin, Mary-Ellen; Wei, Xiao X.; Ng, Thomas; Ravi, Praful; Jacene, Heather Share Save
Share Save
Share Save
Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpoints Minikel, Eric Vallabh; Zhao, Hien T.; Le, Jason; O'Moore, Jill; Pitstick, Rose; Graffam, Samantha; Carlson, George A.; Kavanaugh, Michael P.; Kriz, Jasna; Kim, Jae Beom; Ma, Jiyan; Wille, Holger; Aiken, Judd; McKenzie, Deborah; Doh-Ura, Katsumi; Beck, Matthew; O'Keefe, Rhonda; Stathopoulos, Jacquelyn; Caron, Tyler; Schreiber, Stuart L.; Carroll, Jeffrey B.; Kordasiewicz, Holly B.; Cabin, Deborah E.; Vallabh, Sonia M. Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
A critical site in the core of the CCR5 chemokine receptor required for binding and infectivity of human immunodeficiency virus type 1 Siciliano, SJ; Kuhmann, SE; Weng, YM; Madani, N; Springer, MS; Lineberger, JE; Danzeisen, R; Miller, MD; Kavanaugh, MP; DeMartino, JA; Kabat, D Share Save
Share Save
Share Save
Share Save